Tumour Necrosis Factor (TNF ) as a Novel Therapeutic Target in Symptomatic Corticosteroid Dependent Asthma

Thorax - United Kingdom
doi 10.1136/thx.2005.045260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Treatment With Tumour Necrosis Factor Inhibitor Oxpentifylline Does Not Improve Corticosteroid Dependent Chronic Active Crohn's Disease.

Gut
Gastroenterology
1997English

Tumour Necrosis Factor-Alpha Production in Human Alveolar Macrophages: Modulation by Inhaled Corticosteroid

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2000English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma

PPAR Research
Drug DiscoveryPharmacology
2020English

Carnitine and Congeners as Regulators of Tumour Necrosis Factor

Mediators of Inflammation
ImmunologyCell Biology
1993English

IgE-dependent Signaling as a Therapeutic Target for Allergies

Trends in Pharmacological Sciences
ToxicologyPharmacology
2012English

Competitive Metabolism of L -Arginine: Arginase as a Therapeutic Target in Asthma

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2011English

Recognition of Human Tumor Necrosis Factor Α (TNF-α) by Therapeutic Antibody Fragment

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

The Effect of Tumour Necrosis Factor-Α (TNF-α) Muteins on Human Neutrophilsin Vitro

Mediators of Inflammation
ImmunologyCell Biology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy